Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor
Oncology research progresses, yet cancer remains the largest medical need. The use of a medication with an accessible lead molecule shows great potential for long-term cancer therapy. It may help target cancer therapy and drug resistance. This work uses FDA-approved, clinically proven compounds to b...
Saved in:
| Main Authors: | Rahul D. Jawarkar, Praveen Sharma, Sachin Jain, Umang Shah, Magdi EA Zaki, Sami A Al-Hussain, Suraj Mali, Chin-Hung Lai, Vijay H. Masand, Vivek T Humne |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Taibah University for Science |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16583655.2024.2336674 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-κB
by: Rahul D. Jawarkar, et al.
Published: (2024-12-01) -
In silico discovery of druggable targets in Citrobacter koseri using echinoderm metabolites and molecular dynamics simulation
by: Bayan A. Alhaidhal, et al.
Published: (2024-11-01) -
Targeting <i>Plasmodium falciparum</i> Schizont Egress Antigen-1 in Infected Red Blood Cells: Docking-Based Fingerprinting, Density Functional Theory, Molecular Dynamics Simulations, and Binding Free Energy Analysis
by: Hassan H. Almasoudi, et al.
Published: (2025-02-01) -
A novel double fusion of EML4-ALK and PLEKHA7-ALK contribute to rapid progression of lung adenocarcinoma: a case report and literature review
by: Zhongzhao Wang, et al.
Published: (2024-11-01) -
Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer
by: Dafeng Guo, et al.
Published: (2022-12-01)